Chin-Chung Tseng

Title: Innovations by Chin-Chung Tseng in Medical Research

Introduction

Chin-Chung Tseng is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of encapsulating peritoneal sclerosis. His innovative methods and research have the potential to impact patient care and treatment options.

Latest Patents

Chin-Chung Tseng holds 1 patent for a method related to treating encapsulating peritoneal sclerosis. This patent describes a method for estimating the risk for a subject suffering from this condition. The method involves measuring the expression level of at least one microRNA from a sample of the subject. The microRNA is selected from a specific group, including miR-17, miR-100, miR-155, miR-202, miR-422a, and miR-483. By comparing the expression level of the microRNA in the sample to that of a control, it can be determined if the subject is at risk for encapsulating peritoneal sclerosis.

Career Highlights

Chin-Chung Tseng is affiliated with National Central University, where he continues to engage in research and innovation. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through innovative methodologies.

Collaborations

Chin-Chung Tseng has collaborated with notable colleagues, including Chien-Lung Chen and Nian-Han Ma. These collaborations have contributed to the advancement of research in their respective fields.

Conclusion

Chin-Chung Tseng's contributions to medical research, particularly through his patent on encapsulating peritoneal sclerosis, highlight his role as an innovator in the field. His work exemplifies the importance of research and innovation in improving healthcare solutions.